Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation

Human Reproduction

Volumn 19, Issue 5, 2004, Pages 1176-1180

  Tesarik, Jan ^a,b   Hazout, André ^c   Mendoza, Carmen ^a,d  

^a Molecular Assisted Reproduction and Genetics   (Spain)

^b LABORATOIRE D EYLAU   (France)

^c ARCEFAR   (France)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Embryo developmental potential; GnRH agonist; Implantation; Oocyte donation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; ETHINYLESTRADIOL PLUS GESTODENE; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; NORETHISTERONE ACETATE; PLACEBO; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRI MINULET; TRIPTORELIN;

ABORTION; ADULT; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; DELIVERY; DRUG MECHANISM; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; NIDATION; OOCYTE DONATION; PROSPECTIVE STUDY; RECIPIENT; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; TWIN PREGNANCY;

EID: 2442568858     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh235     Document Type: Article

References (29)

1. Balasch J, Martinez F, Jové I, Cabré L, Coroleu B, Barri PN and Vanrell JA (1993) Inadvertent honadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod 8,1148-1151.
2. Barnea ER, Kaplan M and Naor Z (1991) Comparative stimulatory effect of gonadotropin releasing hormone (GnRH) and GnRH agonist upon pulsatile human chorionic gonadotropin secretion in superfused placental explants: reversible inhibition by a GnRH antagonist. Hum Reprod 6,1063-1069.
3. Campbell MJ, Julious SA and Altman DG (1995) Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. Br Med J 311,1145-1148.
4. Elefant E, Biour B, Blumberg-Tick J, Roux C and Thomas F (1993) Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil Steril 63,1111-1113.
5. Gartner B, Moreno C, Marinaro A, Remohi J, Simon C and Pellicer A (1997) Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle. Hum Reprod 12,2557-2559.
6. 6 LH-RH microcapsules during pregnancy: a case report. Hum Reprod 5,123-124.
7. Har-Toov J, Brenner SH, Jaffa A, Yavetz H, Peyser MR and Lessing JB (1993) Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause. Fertil Steril 59,446-447.
8. Herman A, Ron-El R, Golan A, Nachum H, Soffer Y and Caspi E (1992) Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone. Hum Reprod 7,465-468.
9. Hsueh AJW and Jones PBC (1981) Extrapituitary actions of gonadotropin releasing hormone. Endocr Rev 2,437-455.
10. Isherwood PJ, Ibrahim ZA, Matson PL, Morroll DR, Burslem RW and Lieberman BA (1990) Endocrine changes in women conceiving during treatment with a LHRH agonist. Hum Reprod 5,409-412.
11. Iwashita M, Kudo Y, Shinozaki Y and Takeda Y (1993) Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J 40,539-544.
12. Jackson AE, Curtis P, Amso N and Shaw RW (1992) Exposure to LHRH agonist in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. Hum Reprod 7,465-468.
13. Kang IS, Kuehl TJ and Siler-Khodr TM (1989) Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome on the baboon. Fertil Steril 52,846-853.
14. Legro RS, Finegood D and Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83,2694-2698.
15. Lin L, Roberts VJ and Yen S (1995) Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 80,580-585.
16. Raga F, Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F and Polan ML (1999) The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140,3705-3712.
17. Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, Tesarik J and Greco E (2002) Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod 17,1852-1855.
18. Ron-El R, Golan A, Herman A, Raziel A, Soffer Y and Caspi E (1990) Midluteal gonadotropin-releasing hormone analog administration in early pregnancy. Fertil Steril 53,572-574.
19. Siler-Khodr TM, Smikle CB, Sorem KA, Grayson MA, Spencer DK, Yoder BK and Khodr GS (1997) Effect of excessive GnRH-binding substance on circulating maternal hCG in human pregnancy. Early Pregn 3, 10-14.
20. Skarin G, Nillius SJ and Wide L (1982) Failure to induce early abortion by huge doses of a superactive LHRH agonist in women. Contraception 26,457-463.
21. Smitz J, Camus M, Devroey P, Bollen N, Tournaye H and Van Steirteghem AC (1991) The influence of inadvertent intranasal buserelin administration in early pregnancy. Hum Reprod 6,290-293.
22. Tesarik J and Greco E (1999) The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum Reprod 14,1318-1323.
23. Tesarik J and Mendoza C (2002) Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 17,3129-3137.
24. Tesarik J, Junca AM, Hazout A, Aubriot FX, Nathan C, Cohen-Bacrie P and Dumont-Hassan M (2000) Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum Reprod 15,1396-1399.
25. Tesarik J, Hazout A and Mendoza C (2003) Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 7,59-64.
26. Weissman A and Shoham Z (1993) Favourable pregnancy outcome after administration of a long-acting gonadotropin-releasing hormone agonist in the mid-luteal phase. Hum Reprod 8,496-497.
27. Wilshire GB, Emmi AM, Gagliardi CC and Weiss G (1993) Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril 60,980-983.
28. World Health Organization (1999) WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn, Cambridge University Press, Cambridge.
29. Young DC, Snabes MC and Poindexter AN (1993) GnRH agonist exposure during the first trimester of pregnancy. Obstet Gynecol 81,587-589.